151 related articles for article (PubMed ID: 17804732)
1. Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression.
He Y; Franco OE; Jiang M; Williams K; Love HD; Coleman IM; Nelson PS; Hayward SW
Cancer Res; 2007 Sep; 67(17):8188-97. PubMed ID: 17804732
[TBL] [Abstract][Full Text] [Related]
2. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
[TBL] [Abstract][Full Text] [Related]
3. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model.
Sauter ER; Herlyn M; Liu SC; Litwin S; Ridge JA
Clin Cancer Res; 2000 Feb; 6(2):654-60. PubMed ID: 10690551
[TBL] [Abstract][Full Text] [Related]
4. Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1.
Chen Y; Martinez LA; LaCava M; Coghlan L; Conti CJ
Oncogene; 1998 Apr; 16(15):1913-20. PubMed ID: 9591774
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells.
Al Moustafa AE; Foulkes WD; Wong A; Jallal H; Batist G; Yu Q; Herlyn M; Sicinski P; Alaoui-Jamali MA
Oncogene; 2004 Jul; 23(30):5252-6. PubMed ID: 15229656
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.
Drobnjak M; Osman I; Scher HI; Fazzari M; Cordon-Cardo C
Clin Cancer Res; 2000 May; 6(5):1891-5. PubMed ID: 10815912
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.
Katayama Y; Sakai A; Okikawa Y; Oue N; Asaoku H; Sasaki A; Imanaka F; Tsujimoto T; Takimoto Y; Masuda R; Nakaju N; Otsuki T; Yasui W; Kimura A
Int J Oncol; 2004 Sep; 25(3):579-95. PubMed ID: 15289859
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
[TBL] [Abstract][Full Text] [Related]
12. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis.
Bektic J; Pfeil K; Berger AP; Ramoner R; Pelzer A; Schäfer G; Kofler K; Bartsch G; Klocker H
Prostate; 2005 Sep; 64(4):332-40. PubMed ID: 15754346
[TBL] [Abstract][Full Text] [Related]
13. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
[TBL] [Abstract][Full Text] [Related]
14. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV
Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859
[TBL] [Abstract][Full Text] [Related]
15. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of N-terminal of p55PIK--regulatory subunit of phosphoinositide-3 kinase--on proliferation of gastric cancer cell line MGC803 and its mechanism].
Sun XJ; Zhao M; Yuan XH; Yu Q; Zheng LM; Fang MJ; Huang CZ
Ai Zheng; 2006 Mar; 25(3):264-8. PubMed ID: 16536976
[TBL] [Abstract][Full Text] [Related]
17. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.
Giannoni E; Bianchini F; Masieri L; Serni S; Torre E; Calorini L; Chiarugi P
Cancer Res; 2010 Sep; 70(17):6945-56. PubMed ID: 20699369
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
20. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
Ben Sahra I; Laurent K; Loubat A; Giorgetti-Peraldi S; Colosetti P; Auberger P; Tanti JF; Le Marchand-Brustel Y; Bost F
Oncogene; 2008 Jun; 27(25):3576-86. PubMed ID: 18212742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]